Stock Forecast Based On a Predictive Algorithm | I Know First |June 2015 - Page 6 of 32 - Stock Forecast Based On a Predictive Algorithm

Stock Market Outlook Based on Machine Learning: Up to 142.44% in 3 Months

June 25, 2015

Package Name: Industry Package - Biotech Stocks
Recommended Positions: Long
Forecast Length: 3 Months (3/24/15 - 6/24/15)
I Know First Average: 18.94%

Market Forecast: an Average of 26.33% in 12 Months

June 25, 2015

Package Name: Best Small Cap Stocks
Recommended Positions: Long
Forecast Length: 1 Year (6/24/2014-6/24/2015)
I Know First Average: 26.33%

Momentum Strategy Based On Artificial Intelligence: Up to 17.85% Return in 14 Days

June 25, 2015

Package Name: Small Cap Stocks
Forecast Length: 14 Days (6/10/15 - 6/24/15)
I Know First Average: 5.99%

Stock Trends Based On Artificial Intelligence: Up To 85.29% Return In 1 Month

June 25, 2015

Package Name: Top 10 Aggressive Stock
Recommended Positions: Long
Forecast Length: 1 Month (5/20/2015 - 6/20/2015)
I Know First Average: 10.67%

GILD Stock News: Continue Buying At Current Prices

June 25, 2015

Summary

Gilead Sciences’ stock price has increased over 50% in the last year, in most part because of the rapid growth of its HCV drugs.
Sales of these drugs will not fall off, with plenty of additional growth still to be had.
Along with the success in the HIV market and potential in the oncology field, the company’s pipeline is currently robust.
With a cheap valuation and a large cash pile with which to return value to shareholders, this stock is still attractive to long-term investors.
I Know First algorithm is bullish on Gilead Sciences over the next year, believing the stock price will climb to new highs.

KITE Stock – Quick Win: 12.79% Gain In 7 Days

June 25, 2015

Kite Pharma (KITE) was a top stock pick based on predictive algorithm recommended to I Know First subscribers on June 15th for the 7-Day time horizon. KITE had a signal of 35.16 and a predictability of 0.13. In accordance with the algorithm, the company reported short-term capital gains of 12.79%. Kite Pharma was part of the stock forecast that can be found in the "BioTech-Stocks" Package. The full Top 10 BioTech Stocks forecast includes a daily prediction for a total of 20 stocks with bullish and bearish signals: